Generali Asset Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.11M Sell
9,998
-4,229
-30% -$907K 0.04% 279
2026
Q1
$3.15M Buy
14,227
+4,264
+43% +$1.04M 0.07% 240
2025
Q4
$2.53M Sell
9,963
-5,230
-34% -$1.31M 0.05% 259
2025
Q3
$3.76M Buy
15,193
+924
+6% +$221K 0.08% 213
2025
Q2
$3.43M Buy
14,269
+2,331
+20% +$543K 0.08% 222
2025
Q1
$2.71M Buy
11,938
+7,739
+184% +$1.7M 0.07% 261
2024
Q4
$863K Buy
+4,199
New +$921K 0.02% 375

Other funds holding STE

Generali Asset Management's STE Position: Q2 2026 in Review

Generali Asset Management reduced its Steris (STE) stake by 30% in Q2 2026, selling an estimated $907K and leaving 9,998 shares worth $2.11M. The position accounts for 0.04% of the portfolio, ranked #279.

Generali Asset Management first reported a position in STE in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.76M in Q3 2025. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Generali Asset Management held 9,998 shares of Steris worth $2.11M as of Q2 2026.
  • Generali Asset Management sold 4,229 Steris shares in Q2 2026, an estimated $907K.
  • Steris made up 0.04% of Generali Asset Management's portfolio in Q2 2026, its #279 holding.
  • Generali Asset Management first reported a position in Steris in Q4 2024 and has held it in 7 quarters since.
  • Generali Asset Management's Steris position peaked at $3.76M in Q3 2025.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.